foxo4-dri senolytic 2024 study The disordered p53 transactivation domain is the target of FOXO4 and the compound Senolytics: from pharmacological inhibitors to

foxo4-dri senolytic 2024 study

foxo4-dri senolytic 2024 study The disordered p53 transactivation domain is the target of FOXO4 and the compound Senolytics: from pharmacological inhibitors to

Name: foxo4-dri senolytic 2024 study The disordered p53 transactivation domain is the target of FOXO4 and the compound Senolytics: from pharmacological inhibitors to
Brand: inesschwebach.de
SKU: 78247205660
Price: 22.94 USD
Availability: InStock
Rating: 4.1575 (6 reviews)

SKU: 78247205660

4.2

EUR22.94 EUR56.94

Pay in 4 interest-free payments of $5.74 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 29 - Nov 3

Description

10.1016/j.fct.2021.112213 Food Chem

Approximately 10% of the standard injectable dose of 1 mg is absorbed, which allows for rapid replacement in patients with severe deficiency or severe neurologic sy mptoms

Not for human consumption, veterinary use, or clinical application

Standard dilution: Add 2 ml of BAC water to the 10mg vial final concentration 5 mg/ml (5,000 mcg/ml)

Description Epithalon Peptide 10mg (Lyophilized Peptide) For Research Use Only Epithalon (also known as Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the naturally occurring pineal gland peptide Epithalamin